Your browser doesn't support javascript.
loading
Efficacy and Safety of Ixekizumab Versus Adalimumab in Biologic-naïve Patients With Active Psoriatic Arthritis and Moderate-to-severe Psoriasis: 52-week Results From the Randomized SPIRIT-H2H Trial.
Reich, Kristian; Kristensen, Lars Erik; Smith, Saxon D; Rich, Phoebe; Sapin, Christophe; Leage, Soyi Liu; McKenzie, Robert; Schuster, Christopher; Riedl, Elisabeth; Gooderham, Melinda.
Afiliación
  • Reich K; Center for Translational Research in Inflammatory Skin Diseases, Institute for Health Services Research in Dermatology and Nursing, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Kristensen LE; Musculoskeletal Statistics Unit, The Parker Institute, Copenhagen University Hospital, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark.
  • Smith SD; The Dermatology and Skin Cancer Centre, St Leonards, and Discipline of Dermatology, Sydney Medical School, University of Sydney, Sydney, Australia.
  • Rich P; Oregon Dermatology and Research, Portland, Oregon, USA.
  • Sapin C; Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Leage SL; Eli Lilly and Company, Indianapolis, Indiana, USA.
  • McKenzie R; Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Schuster C; Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Riedl E; Department of Dermatology, Medical University of Vienna, Vienna, Austria.
  • Gooderham M; Eli Lilly and Company, Indianapolis, Indiana, USA.
Dermatol Pract Concept ; 12(2): e2022104, 2022 May.
Article en En | MEDLINE | ID: mdl-35646453

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Prognostic_studies Aspecto: Patient_preference Idioma: En Revista: Dermatol Pract Concept Año: 2022 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Austria

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Prognostic_studies Aspecto: Patient_preference Idioma: En Revista: Dermatol Pract Concept Año: 2022 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Austria